Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Reddit
RDDT
|
+$196M |
| 2 |
Nike
NKE
|
+$183M |
| 3 |
Alibaba
BABA
|
+$172M |
| 4 |
Shopify
SHOP
|
+$167M |
| 5 |
TSMC
TSM
|
+$154M |
Top Sells
| 1 |
Palantir
PLTR
|
+$1.18B |
| 2 |
Microsoft
MSFT
|
+$678M |
| 3 |
Meta Platforms (Facebook)
META
|
+$350M |
| 4 |
Apple
AAPL
|
+$202M |
| 5 |
Micron Technology
MU
|
+$202M |
Sector Composition
| 1 | Technology | 20.89% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 14.08% |
| 4 | Industrials | 8.96% |
| 5 | Financials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
US GoldMining
USGO
$116M
| $91K | ﹤0.01% |
+10,571
| New | +$91K |
|
3302
Traws Pharma
TRAW
$12.9M
| $89.3K | ﹤0.01% |
+10,052
| New | +$89.3K |
|
3303
SurgePays
SURG
$55.9M
| $87.9K | ﹤0.01% |
49,400
+15,000
| +44% | +$26.7K |
|
3304
Fathom Holdings
FTHM
$66.7M
| $87.7K | ﹤0.01% |
57,300
+2,600
| +5% | +$3.98K |
|
3305
Gulf Resources
GURE
$10M
| $86.9K | ﹤0.01% |
153,168
-1,524
| -1% | -$865 |
|
|
QNRX
3306
Quoin Pharmaceuticals
QNRX
$4.36M
| $86.6K | ﹤0.01% |
3,803
+2,698
| +244% | +$61.5K |
|
3307
Relmada Therapeutics
RLMD
$53.4M
| $85.5K | ﹤0.01% |
164,513
+138,625
| +535% | +$72.1K |
|
3308
System1
SST
$65.2M
| $85.3K | ﹤0.01% |
9,500
+1,070
| +13% | +$9.61K |
|
|
OPTN
3309
DELISTED
OptiNose
OPTN
| $85.2K | ﹤0.01% |
12,748
-2,385
| -16% | -$15.9K |
|
3310
ClearSign Technologies
CLIR
$29.7M
| $84.2K | ﹤0.01% |
+58,500
| New | +$84.2K |
|
3311
Werewolf Therapeutics
HOWL
$64.5M
| $84.2K | ﹤0.01% |
56,900
-95,300
| -63% | -$141K |
|
|
KNDI
3312
Kandi Technologies Group
KNDI
$113M
| $83.9K | ﹤0.01% |
69,934
+22,934
| +49% | +$27.5K |
|
3313
RenovoRx
RNXT
$42.9M
| $83.7K | ﹤0.01% |
+64,900
| New | +$83.7K |
|
3314
VYNE Therapeutics
VYNE
$7.82M
| $83.6K | ﹤0.01% |
24,943
-61,700
| -71% | -$207K |
|
|
YI
3315
111 Inc
YI
$52.3M
| $83.1K | ﹤0.01% |
13,345
-80
| -0.6% | -$498 |
|
3316
SKYX Platforms
SKYX
$126M
| $82.2K | ﹤0.01% |
+70,850
| New | +$82.2K |
|
3317
United Homes Group
UHG
$249M
| $81.4K | ﹤0.01% |
19,247
+555
| +3% | +$2.35K |
|
3318
Cytosorbents Corp
CTSO
$59.3M
| $80.1K | ﹤0.01% |
88,020
+8,400
| +11% | +$7.64K |
|
|
FRSX
3319
Foresight Autonomous Holdings
FRSX
$8.24M
| $78.4K | ﹤0.01% |
7,565
+1,714
| +29% | +$17.8K |
|
3320
PharmaCyte Biotech
PMCB
$6.86M
| $77.4K | ﹤0.01% |
49,300
-400
| -0.8% | -$628 |
|
|
SOHO
3321
Sotherly Hotels
SOHO
$16M
| $77.2K | ﹤0.01% |
82,914
-19,000
| -19% | -$17.7K |
|
3322
Sensei Biotherapeutics
SNSE
$10.7M
| $76.8K | ﹤0.01% |
7,840
-2,939
| -27% | -$28.8K |
|
|
INCR
3323
Intercure
INCR
$86.4M
| $76.8K | ﹤0.01% |
48,300
-500
| -1% | -$795 |
|
3324
SiNtx Technologies
SINT
$12M
| $76.7K | ﹤0.01% |
+21,900
| New | +$76.7K |
|
|
QSG
3325
QuantaSing Group
QSG
$450M
| $76.2K | ﹤0.01% |
35,300
+900
| +3% | +$1.94K |
|